Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren's syndrome without disease modifying treatment.

Nived, Per; Saxne, Tore; Geborek, Pierre; Mandl, Thomas; Skattum, Lillemor; Kapetanovic, Meliha C

Nived, Per; Saxne, Tore; Geborek, Pierre; Mandl, Thomas; Skattum, Lillemor; Kapetanovic, Meliha C.

Afiliación

Nived P; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital, SE-221 85 Lund, Sweden.
Saxne T; 2Department of Infectious Diseases, Central Hospital Kristianstad, J A Hedlunds väg 5, SE-291 85 Kristianstad, Sweden.
Geborek P; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital, SE-221 85 Lund, Sweden.
Mandl T; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital, SE-221 85 Lund, Sweden.
Skattum L; 3Department of Clinical Sciences Malmö, Section of Rheumatology, Lund University, Skåne University Hospital, Malmö, Sweden.
Kapetanovic MC; 4Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden.

BMC Rheumatol ; 2: 12, 2018.

Article en En | MEDLINE | ID: mdl-30886963

Palabras clave

Pneumococcal conjugate vaccine; Pneumococcal vaccination; Rheumatoid arthritis; Sjögren's syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: BMC Rheumatol Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: BMC Rheumatol Año: 2018 Tipo del documento: Article